LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | GSK1059615 | 3.33 | uM | LJP6 | 1 | C02 | 72 | hr | 1401 | 803 | 4139 | 0.1940 | -0.2999 |
| SK-BR-3 | GSK1059615 | 3.33 | uM | LJP6 | 2 | C02 | 72 | hr | 1401 | 1101 | 4095 | 0.2688 | -0.1445 |
| SK-BR-3 | GSK1059615 | 3.33 | uM | LJP6 | 3 | C02 | 72 | hr | 1401 | 966 | 4272 | 0.2261 | -0.2066 |
| SK-BR-3 | GSK1059615 | 3.33 | uM | LJP5 | 1 | E02 | 72 | hr | 1401 | 458 | 3978 | 0.1151 | -0.5243 |
| SK-BR-3 | GSK1059615 | 3.33 | uM | LJP5 | 2 | E02 | 72 | hr | 1401 | 1272 | 4213 | 0.3019 | -0.0592 |
| SK-BR-3 | GSK1059615 | 3.33 | uM | LJP5 | 3 | E02 | 72 | hr | 1401 | 1255 | 4545 | 0.2761 | -0.0630 |
| SK-BR-3 | GSK1059615 | 10 | uM | LJP6 | 1 | C01 | 72 | hr | 1401 | 489 | 4139 | 0.1181 | -0.4903 |
| SK-BR-3 | GSK1059615 | 10 | uM | LJP6 | 2 | C01 | 72 | hr | 1401 | 808 | 4095 | 0.1973 | -0.2995 |
| SK-BR-3 | GSK1059615 | 10 | uM | LJP6 | 3 | C01 | 72 | hr | 1401 | 785 | 4272 | 0.1837 | -0.3027 |
| SK-BR-3 | GSK1059615 | 10 | uM | LJP5 | 1 | E01 | 72 | hr | 1401 | 504 | 3978 | 0.1267 | -0.4931 |
| SK-BR-3 | GSK1059615 | 10 | uM | LJP5 | 2 | E01 | 72 | hr | 1401 | 870 | 4213 | 0.2065 | -0.2594 |
| SK-BR-3 | GSK1059615 | 10 | uM | LJP5 | 3 | E01 | 72 | hr | 1401 | 1209 | 4545 | 0.2660 | -0.0834 |
| SK-BR-3 | Brivanib | 0.04 | uM | LJP5 | 1 | P18 | 72 | hr | 1401 | 3572 | 3978 | 0.8978 | 0.8618 |
| SK-BR-3 | Brivanib | 0.04 | uM | LJP5 | 2 | P18 | 72 | hr | 1401 | 4182 | 4213 | 0.9926 | 0.9906 |
| SK-BR-3 | Brivanib | 0.04 | uM | LJP5 | 3 | P18 | 72 | hr | 1401 | 4777 | 4545 | 1.0508 | 1.0593 |
| SK-BR-3 | Brivanib | 0.12 | uM | LJP5 | 1 | P17 | 72 | hr | 1401 | 4035 | 3978 | 1.0142 | 1.0188 |
| SK-BR-3 | Brivanib | 0.12 | uM | LJP5 | 2 | P17 | 72 | hr | 1401 | 4068 | 4213 | 0.9655 | 0.9563 |
| SK-BR-3 | Brivanib | 0.12 | uM | LJP5 | 3 | P17 | 72 | hr | 1401 | 4389 | 4545 | 0.9655 | 0.9590 |
| SK-BR-3 | Brivanib | 0.37 | uM | LJP5 | 1 | P16 | 72 | hr | 1401 | 3798 | 3978 | 0.9546 | 0.9392 |
| SK-BR-3 | Brivanib | 0.37 | uM | LJP5 | 2 | P16 | 72 | hr | 1401 | 4105 | 4213 | 0.9743 | 0.9675 |
| SK-BR-3 | Brivanib | 0.37 | uM | LJP5 | 3 | P16 | 72 | hr | 1401 | 4712 | 4545 | 1.0365 | 1.0427 |
| SK-BR-3 | Brivanib | 1.11 | uM | LJP5 | 1 | P15 | 72 | hr | 1401 | 3846 | 3978 | 0.9667 | 0.9555 |
| SK-BR-3 | Brivanib | 1.11 | uM | LJP5 | 2 | P15 | 72 | hr | 1401 | 4011 | 4213 | 0.9520 | 0.9390 |
| SK-BR-3 | Brivanib | 1.11 | uM | LJP5 | 3 | P15 | 72 | hr | 1401 | 4771 | 4545 | 1.0495 | 1.0578 |
| SK-BR-3 | Brivanib | 3.33 | uM | LJP5 | 1 | P14 | 72 | hr | 1401 | 3837 | 3978 | 0.9644 | 0.9524 |